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Aging is a complex biological process marked by the 
gradual decline of a multitude of physiological 
processes [1-5]. Some functional changes, such as 
decreased muscular strength, have a tremendous impact  
on the quality of life. Normal aging involves sarcopenia, 

















































strength that develops despite dietary interventions and 
increased physical activity [6,7]. The physical, 
psychological and socio-economic impact of sarcopenia 
is largely underestimated despite the fact that it is a 
leading contributor to debilitating injuries due to 
repetitive falls, loss of independence, and a reduced 



























Abstract: Muscle  atrophy  alone  is  insufficient  to  explain  the  significant decline  in  contractile  force of  skeletal muscle
during normal aging. One contributing factor to decreased contractile force in aging skeletal muscle could be compromised
excitation‐contraction (E‐C) coupling, without sufficient available Ca2+ to allow for repetitive muscle contractility, skeletal
muscles naturally become weaker. Using biophysical approaches, we previously  showed  that  store‐operated Ca2+ entry
(SOCE)  is  compromised  in  aged  skeletal  muscle  but  not  in  young  ones.  While  important,  a  missing  component  from
previous  studies  is  whether  or  not  SOCE  function  correlates  with  contractile  function  during  aging.  Here  we  test  the
contribution  of  extracellular  Ca2+  to  contractile  function  of  skeletal muscle  during  aging.  First, we  demonstrate  graded
coupling  between  SR  Ca2+  release  channel‐mediated  Ca2+  release  and  activation  of  SOCE.  Inhibition  of  SOCE  produced
significant  reduction of  contractile  force  in  young  skeletal muscle, particularly  at  high  frequency  stimulation,  and  such
effects  were  completely  absent  in  aged  skeletal  muscle.  Our  data  indicate  that  SOCE  contributes  to  the  normal
physiological  contractile  response of  young  healthy  skeletal muscle  and  that  defective  extracellular  Ca2+  entry  through
SOCE contributes to the reduced contractile force characteristic of aged skeletal muscle.  
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Understanding the cellular mechanisms that 
contribute to sarcopenia is essential for the 
development of effective treatments and improved 
care for the elderly.  
 
While many cellular modifications [8-13] may 
contribute to muscle aging, excitation-contraction (E-C) 
coupling is an elemental process that must be 
considered because it is so integral to the control of 
muscle contractility.  E-C coupling requires the close 
coordination of extracellular Ca2+ ([Ca2+]o) entry or 
voltage-sensing changes with Ca2+ release from the 
principal intracellular storage organelle, the 
sarcoplasmic reticulum (SR). Changes in E-C coupling 
machinery may act as causative factors for, or adaptive 
mechanisms in, muscle aging that directly contribute to 
muscle weakness. Decreased muscle function during 
aging has been associated with muscle fiber 
denervation, loss of motor units, and motor unit 
remodeling. Moreover, altered function of several triad 
junction proteins involved in the regulation and 
transduction of E-C coupling has been shown to 
contribute to disrupted Ca2+ homeostasis in aged 
skeletal muscle [14-17].   
 
Thus, reduced homeostatic capacity for intracellular 
Ca2+ movement may underlie the progression of 
sarcopenia and contractile dysfunction during muscle 
aging.  We have previously demonstrated that changes 
in aged skeletal muscle Ca2+ homeostasis are 
accompanied by distinct modification of the structure 
and protein composition of triad junctional complexes. 
We found that expression of mitsugumin 29 (MG29), a 
triad junction protein, drastically decreases with aging 
and that skeletal muscle from adolescent MG29 
knockout mice contain many of the phenotypic changes 
we observe in aged skeletal muscle, including defective 
store-operated Ca2+ entry (SOCE) [16-18]. SOCE is an 
important mechanism linking [Ca2+]o entry and 
intracellular Ca2+ storage, in particular during the 
repetitive cycles of E-C coupling when a reduced SR 
Ca2+ store necessitates the activation of SOCE. Several 
previous studies have demonstrated that SOCE plays a 
role in muscle fatigue [19-22] as part of a functional 
stress response in skeletal muscle [18].   
 
However, to date, to the best of our knowledge, no 
systematic studies have yet been performed to test if a 
reduced SOCE function contributes to the decreased 
contractile capacity of aged skeletal muscles. 
Furthermore, it is not known if and how SOCE 
contributes to normal muscle contractility, two essential 
physiological questions that we aimed to answer in 
these novel studies.  
To examine the contribution of SOCE to muscle 
contractile function during aging, we made use of ex 
vivo contractility assays, in which the components of 
the extracellular milieu surrounding isolated anatomical 
muscles can be precisely manipulated. This allowed use 
of pharmacological and experimental manipulations to 
alter the function of SOCE in order to define its 
physiological role in young and aged skeletal muscle. 
We found that reagents that prevent [Ca2+]o entry reduce 
contractile force in skeletal muscle, an effect that was 
more prominent at high frequency stimulation as 
compared to lower frequencies of stimulation, and that 
SOCE is a robust mechanism of [Ca2+]o entry in young, 
healthy skeletal muscle. Of utmost importance, we also 
demonstrate that SOCE is compromised in aged skeletal 
muscle, and that loss of this physiological component 
contributes to at least a part of the decreased contractile 
force generation typical of aged muscle.  
 
Our novel studies that now link SOCE with muscle 
contractile function, suggest that manipulation of SOCE 
may present a therapeutically valid target for 
improvement of contractile function and, potentially the 




Extracellular Ca2+ contributes to tetanic contractile 
force in skeletal muscle 
 
In the first series of ex vivo contractility experiments, it 
was critical to validate that muscle preparation 
deterioration or run-down did not play any role in our 
results. Fig. 1 shows an example that is representative 
of the muscle preparations used in our studies. Fig. 1A 
demonstrates that our preparations can undergo very 
lengthy protocols without any detectable run-down of 
contractile force. When a single muscle fiber is 
dissected from the intact muscle, it produces a maximal 
tetanic force that is equivalent to the amount force 
produced by the same fiber after it is permeabilized 
with Triton X-100 and maximally activated with 
calcium (Figs. 1B, C). These results illustrate the 
robustness of our preparations and the validity of our 
force calibrations. 
 
SOCE is dependent upon extracellular calcium. To 
begin testing the role of extracellular Ca2+ in skeletal 
muscle contractility, Ca2+ was removed from the 
extracellular solution bathing intact, isolated extensor 
digitorum longus (EDL, glycolitic mostly ast-twitch ) 
muscle fibers by chelation with 0.1 mM EGTA. Under 
these conditions, we observed a decrease in the 
contractile force following high frequency stimulation, 
while the low frequency component is not significantly  
  










































altered (Fig. 2A). This suggests that during high 
frequency tetanic contractions, repetitive cycles of SR 
Ca2+ release results in loss of Ca2+ from intracellular SR 
stores to trigger entry of Ca2+ into muscle fibers. In 
multiple experiments, we observed full recovery of 
contractile force upon restoration of 2.5 mM [Ca2+]o by 
washout of EGTA-containing  solution (n=18/20) (Fig. 
2B). Note that both the initial loss of force and recovery 
after washout are rapid, suggesting that the effect of 
[Ca]o may be related to direct shuttling of Ca2+ across 
the sarcolemmal membrane through mechanisms that 
these type of experiments are not able to reveal. Our 
next step was to investigate if the extracellular Ca2+ 










































in the soleus (SOL, oxidative mostly slow-twitch) 
muscle. We found that removal of extracellular Ca2+ 
actually produced a larger drop in contractile force in 
young SOL as compared to young EDL muscles (Fig. 
2C-D). Further evidence of the necessity of [Ca2+]o 
entry in the maintenance of skeletal muscle contractility 
is provided by a series of experiments that inhibit 
[Ca2+]o entry through inclusion of NiCl2 in the extra-
cellular solution, which has been shown to specifically 
inhibit a component of Ca2+ entry in smooth muscle 
cells that is not affected by either nifedipine or 
verapamil, which suggest its selectivity to block the 
SOCE machinery [23,24]. Since the experiments shown 
in Fig. 2 were performed at ambient temperature (~25°C) 
 
Figure  1. Original  and  unfiltered  recording  of  a  SOL muscle  from Wt mice  illustrates  robustness  of  our



























































and physiological mechanisms may display dependence 
on temperature, we conducted these contractility 
experiments involving NiCl2 at the 37°C to establish the 
extent to which Ca2+ entry effects contraction at 
physiologically normal temperature (Fig. 3). These 
experiments revealed that a similar effect of [Ca2+]o 
entry on contractility can be observed at physiological 
temperatures. As shown in Fig. 3A, addition of 1 mM 
Ni2+ to the extracellular solution results in a nearly 
instantaneous drop in the contractile force of isolated 













































sible after washout in the majority of the experiments 
(Fig. 3B, n=9/11). Similarly, the SOL muscles also 
displayed a component of contractile force that is 
sensitive to inhibition by NiCl2 (Fig. 3C). As 
summarized in Figs. 2D and 3D, SOL muscles 
demonstrate a larger Ca2+ dependence component in 
both Ca removal and SOCE blockade with Ni2+. As 
with chelation of [Ca2+]o by EGTA we found that Ni2+ 
has more pronounced effects on the contractile force 
developed during high frequency stimulation than 
during low frequency stimulation, further suggesting 
Figure 2.   Removal of  [Ca2+]o  reduces  tetanic contractile  force  in young skeletal muscle.    (A) An  Intact EDL
muscle was electrically stimulated with low and high frequency in a bath solution with either 2.5 mM [Ca]o (control) or 0
[Ca]o+0.1 mM EGTA.  (B) An  Intact  SOL muscle was electrically  stimulated with high  frequency  in a bath  solution with
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that under conditions of high Ca2+ demand, [Ca2+]o 
exerts a more  significant role in skeletal muscle 
contractility. An intriguing observation during the 
NiCl2 experiments was the transient increase in the 
low frequency force (Fig. 3A). It is possible that at 
these lower frequencies, the addition of Cl- induced 
Ca2+ release from the SR, a phenomenon previously 
reported by Stephenson et al [25]. This result actually 
provides very strong evidence that a drop in force at 
higher frequencies of stimulation in response to NiCl2 
is not artifactual. From the measurement of force-
frequency relationship, one can clearly see that Ni2+ 
effects were more pronounced at higher frequencies of 









































may contribute to DPH muscle contractility under 
conditions of higher demand, which might have 
important clinical implications, since DPH fatigue can 
lead to serious disease and death. In Fig. 4B, DPH 
muscles were contracted with a high frequency of 
200Hz. Clearly, a fast initial drop in force within 1min 
is easily detected. This initial drop in force is followed 
by an additional time-dependent force reduction 
component, since a further reduction in force is 
observed in the following 8min of exposure to Ni2+ 
(Fig. 4B). These data further confirm our findings in 
EDL and SOL muscles, and suggest that SOCE 
response is a universal phenomenon in different 












































Figure  3.    Extracellular  Ni2+  reduces  tetanic  force  in  young  skeletal  muscle.    (A)  An  intact  EDL  muscle  was

































Aged skeletal muscle displays reduced contractile 
force and negligible [Ca2+]o dependence 
 
Extending our contractile measurements to preparations 
of EDL muscles from aged mice, we first confirmed our 
previously determined decrease of ~30% in normalized 
specific contractile force in this tissue (Fig. 5A). Since 
this reduction in force is already normalized to the 
different cross-sectional areas of young and aged 
muscles, such difference is independent of age related 
atrophy. These experiments revealed quite surprising 
phenotypic changes in aged muscle – a remarkable 
suppression of the sensitivity of aged muscle to 
inhibition of contractile force by inhibition of [Ca2+]o 
entry. As illustrated in Fig. 5B, there are no detectable 
effects of Ni2+ on the high-frequency tetanic force in 
aged muscles. Similarly to the young muscles, Ni2+ had 
a tendency to increase the low frequency force, but by 
the end of the recovery force the low frequency force 
returned to its control levels. Over the course of several 
experiments, we found only negligible effects of 
extracellular Ni2+ on muscle contractility (Fig. 5C). 
Additionally, we found that chelating [Ca2+]o with 
EGTA had no significant acute impact on the contractile 
function of aged EDL skeletal muscle (Fig. 5D). 
Complementary experiments in aged soleus muscle 
demonstrated similar effects of Ni2+ and 0[Ca2+]o on 
contractility (Fig. 5D). These results indicate that the 
acute functional contribution of [Ca2+]o to skeletal 


























les, and stands in stark contrast to the significant 
contribution of [Ca2+]o to acute contractility in young 
muscle.  
 
Mechanisms of loss of Ca2+-dependence in aged 
skeletal muscle 
 
Our results indicate that the dependence of skeletal 
muscle on [Ca2+]o is lost in aged muscle. Elucidation of 
the mechanism contributing to this loss of Ca2+-
dependence may provide a therapeutic target for 
increasing contractile force and function in aged 
skeletal muscle or perhaps new insights into the 
prevention of muscle loss in young subjects during 
aging. To establish whether the effect of [Ca2+]o entry 
on contractility of young skeletal muscle was mediated 
by the L-type Ca2+ channel, we incubated the EDL or 
soleus muscles with nifedipine, an inhibitor of this 
channel, at a concentration (10 μM) previously shown 
to block Ca2+ entry via the L-type Ca channel during 
excitation-coupled Ca2+ entry (ECCE) in C2C12 
myotubes [26] As shown in Fig. 6, there was no 
significant decrease in contractility observed with up to 
13 minutes of exposure to nifedipine, a finding in 
agreement with previous reports from Reid et al. 
[27;28]. Therefore, the mechanism that underlies 
[Ca2+]o entry contribution to contractility is likely to 
involve pathways other than those linked to the L-type 
channels.  Our findings further suggest that this 
mechanism must be functional in skeletal muscle from 
 
Figure 4.  Effects of Ni2+ on contractility of young diaphragm muscle. (A) Force vs. frequency relationship in control
diaphragm muscles  (open  circles)  or  diaphragm muscles  treated with NiCl2  (solid  circles).  (n  =  3).  (B)  Intact  diaphragm
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young, but not aged, individuals. Considering our 
previous findings indicate compromised SOCE in aged 
skeletal muscle, we hypothesize that SOCE could be one 
such pathway. To test this hypothesis, we examined how 
abrogated SOCE might affect force production in young 
and aged skeletal muscle. First, we examined the effects 
of BTP-2, which has been shown to be a specific blocker 















































young and aged muscle. We found that BTP-2 reduce the 
high frequency tetanic force produced by EDL and SOL 
muscles from young mice (Fig. 7A and 7B), further 
suggesting that a component of force generation in 
young, healthy skeletal muscles derives from functional 
SOCE. In striking contrast, BTP-2 did not have 
noticeable effects on the contractile force generation of 

















































































Previous studies by Bolotina and colleagues [30,31] 
showed that bromoenol lactone (BEL) is a potent 
inhibitor of SOCE, while studies by Gong and Reid 
found that BEL can reduce contractile force in skeletal 
muscle from young adult mice [32]. Thus, a series of 
studies were conducted a series of experiments to test if 
inhibition of SOCE by BEL produced differential 
effects on contractility in young or aged skeletal muscle 
fibers. Since BEL has not been used to inhibit SOCE in 
primary skeletal muscle, we first validated that BEL 
was effective under these conditions. We conducted 
Ca2+ imaging studies in individual flexor digitorum 
brevis (FDB) muscle cells to measure SOCE using 
Mn2+-quenching of Fura-2 fluorescence to measure 
SOCE [33]. Our data with young isolated FDB muscle 
fibers revealed that 25 µM BEL could almost 
completely inhibit SOCE elicited by depletion of the SR 
Ca2+ stores using thapsigargin (TG) or 
caffeine/ryanodine treatment (Fig. 8). Knowing that 
BEL acted as a very effective blocker of SOCE in 
young FDB muscle cells, we then used mechanically-
skinned muscle fibers to monitor Ca2+ exit from the T-
tubules via SOCE using the fluorescence of Rhod-5N 
trapped in the T-tubule space as a reporter [16,34]. 
Under these conditions, BEL effectively blocked SOCE 
as monitored with confocal imaging of Rhod-5 
fluorescence in young muscle fibers (Fig. 9A), but had 
negligible effect in aged ones (Fig. 9B). Our last series 
of experiments was to investigate the effects of BEL in 
contractility experiments, and we found that BEL can 
reduce the high-frequency force production of young 
EDL muscle (Fig. 10A), providing additional 
pharmacological evidence that extracellular Ca2+ is 
linked to force production in skeletal muscle. When 
these experiments are conducted with aged skeletal 
muscle there is no decrease in contractile force 
following BEL application (Fig. 10B). Thus, the SOCE-
dependent component of skeletal muscle contractility 
that is present in young skeletal muscle is no longer 
active in aged skeletal muscle, and parallels at least part 
of the loss of the contractile force in this tissue [13] (see 
also figures in the manuscript indicating the atrophy-
related and atrophy-independent components of force 





As aging populations grow world-wide (It has been 
estimated that by 2050 more than 200 million humans 
will have sarcopenia), the aging-related decline in 
muscle function becomes a more pressing public health 
concern that requires more effective therapeutic 
approaches, which in turn requires an understanding of 
sarcopenia at a mechanistic level. While a portion of the 
decrease in muscular strength during aging can be 
explained by muscle atrophy, it is clear that other 
components contribute to reduced force production 
during aging. Furthermore, it is unquestionable that an 
array of cellular modifications [8-13] may contribute to 
muscle aging, and the pleiotropic nature of muscle 
aging muscle be recognized and accepted if we are to 
make significant progress towards its prevention and 
management.  
 
While the role of SOCE during aging is largely 
unexplored, we recently had established the novel 
finding that SOCE is compromised in aged skeletal 
muscle [16], but our inaugural studies failed to directly 
link reduced SOCE in aged muscles with decreased 
contractile force in aged muscles. Now, our new data 
reveals that a functionally significant, SOCE-dependent 
component of skeletal muscle contractility in young 
muscle is lost in aged skeletal muscle. A viable 
hypothesis for atrophy-independent muscle weakness in 
aging, therefore, involves substantial abrogation of 
SOCE, a process vital to the full functionality of E-C 
coupling. 
 
Our studies indicate that in young skeletal muscle, 
SOCE contributes to maintenance of contractile force 
under high frequency stimulation, where Ca2+ 
requirements may exceed the capacity of the 
intracellular store to provide for sustained and repetitive 




frequency  stimulation  protocol  demonstrates  that  10  µM
nifedipine lacks an effect in young muscle. 
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the SOCE regulation of contractile force. The fact that 
force generation in skeletal muscle from aged animals is 
significantly reduced under conditions of high-frequency 
stimulation suggest that this tissue has lost its ability to 


















































phenomenon we recently introduced [18]. Our data now 
suggests that SOCE is actually required for repetitive 
stimulation of skeletal muscles, and its loss in aging 
significantly contributes to the loss of contractile 





















































aged skeletal muscle. (A)  Intact EDL muscle stimulated with  low and high frequencies every minute at 37ºC;  in
control  (no  drug)  contractions  are  shown,  followed  by  the  progressive  effect  of  20  µM  BTP‐2. On  average  the
decrease  in  force with  20 µM  it was  19 ±  4%.  (B)    Same protocol  as  in panel A, but using  young  SOL muscles,
representative of 3 experiments. In these 3 experiments force decreased by 31 ± 7% in 15 min in SOL muscles. (C)































Intriguingly, reduced SOCE during the aging process is 
not a phenomenon limited to skeletal muscles, but is 
also present in other tissues, such as fibroblasts and 
neuronal cells [35,36].  In addition, it is clear from the 
recent report by Stiber, that STIM1, and hence SOCE, is 
required for the normal development of skeletal muscle 
[22]. Our findings that [Ca2+]o contributes directly to 
contractility in young skeletal muscles is different than 
previous findings - that [Ca2+]o does not normally 
contribute to skeletal muscle contractility, except in a 
subpopulation of aged muscle fibers [37]. This may be 
due to the fact that most of the earlier studies suggesting 
a relative lack of effect of [Ca2+]o on muscle 
contractility were not performed under conditions that 
could allow detection of the effect that we observe, 
including the fact that many of these studies were 
performed in amphibian muscle, and also in some cases, 
these studies were conducted in single muscle fibers 
that might behave in ways that are different from the 
intact, anatomical muscle. Also, since Delbono and 
collaborators showed that a subpopulation of aged 
muscle fibers were dependent on extracellular calcium 
entry, while another subpopulation was not dependent 
on extracellular calcium entry, it does make sense that 
in a intact muscles, where all muscle fibers are 
combined, such difference is not observed. 
Furthermore, our results come from use of a previously 
unexploited high-frequency stimulation (using 80-200 
Hz of 500-1000ms duration, with single pulses of 1ms 
















































Ca2+ is high to elucidate the functional effects of SOCE 
on the contractility of three distinct intact muscle types 
(EDL, soleus and diaphragm) from mice. In addition, 
more potent SOCE inhibitors are now available and 
utilization of a small but effective concentration of 0.1 
mM EGTA in the zero Ca+2 solution was critical for full 
observation of these effects, likely required to buffer the 
large amount of calcium in the T-tubular system. One of  
Figure 8. Mn+2 quenching of Fura‐2  in FDB muscles of
young muscle validates  the use of BEL as an effective
SOCE  blocker.  Enzymatically  dissociated  FDB  muscle  fibers







aged  muscle.  Confocal  imaging  of  Ca  movement  from  the 






























our most significant findings is that skeletal muscle 
contractile function under conditions of low-frequency 
stimulation remains mostly [Ca2+]o-independent, while 
significant  contribution of SOCE to contractility is 
more prominent under high frequency stimulation. In 
line with our hypothesis that there is a loss of functional 
SOCE in aged muscle, there was no effect on force by 
the application of EGTA, NiCl2, BTP-2, and BEL in 
aged muscle. The utilization of ex vivo, intact isolated 
muscles offers the advantage of robust preparations, as 
evidenced by our previous report that LDH is 
essentially undetectable in the extracellular bathing 
solution of our preparations [38,39]. Our findings 
indicate that the SOCE-dependent component of 
contractility we observed in young muscle is lost in 
aged muscle, which also display reduced SOCE activity 
(See Figs 8-9 and [16]). Such findings provide the 
possibility that increasing SOCE activity in aged muscle 
may restore this lost component of contractile force and 
increase force generation. In light of our present results 
and our recent work with MG29 null mice [16,17], the 
parallels between defective SOCE and reduced MG29 
levels in aged skeletal muscle may be of significant 
physiological import. Indeed, these findings suggest that 
modulation of MG29 function in aged skeletal muscle 
provides a potential therapeutic target to enhance SOCE 
and increase muscle contractility in aged patients. This 
finding is further supported by the recent association of 
mitsugumins in human muscle diseases [40]. Yet, 


























since we recently showed that mice lacking this 
molecule display phenotypic muscle changes that mirror 
muscle wasting and muscle weakness during aging [13]. 
 
In summary, we show for the first time that SOCE plays 
a significant role in normal contractility in young, 
healthy skeletal muscle. In striking contrast, in aged 
skeletal muscle, we now show that compromised SOCE 
is linked to decreased contractile force. We postulate 
that a chronically compromised SOCE leads to an 
equally chronic reduction in the amount of Ca2+ stored 
in the SR, creating a negative feedback loop, less Ca2+ 
is available, less is released, with less force being 
produced. Interestingly, the absolute force produced by 
young, healthy muscles when SOCE is inhibited 
approximates the amount of force produced by aged 
muscles. Thus, SOCE should be seen as an important 
functional biomarker of muscle function during aging, 
and it may provide a suitable target for therapeutic 
intervention for muscle diseases. Whether the loss of 
SOCE contributes to muscle atrophy during sarcopenia, 
or whether it is the reflection of the pleiotropic adaptive 
response during aging, is still very much an open 
question. 
 
MATERIALS AND METHODS 
 
Muscle Preparation [17,34,41]. Intact extensor 
digitorum longus (EDL), diaphragm (DPH) and soleus 















month old, were surgically removed from tendon to 
tendon by blunt dissection and immediately placed in a 
dissecting dish containing a modified bicarbonate 
Ringer solution with the following compositions (mM). 
In the case of the DPH, small bundles were prepared in 
such a way that they could be mounted from the rib 
cage and the central tendon. The pH was adjusted to 
between 7.4 with NaHCO3, followed by the addition of 
fetal bovine serum (to 0.2%) to increase viability of the 
dissected muscle.  The solution was continuously 
aerated with a gas mixture consisting of 95% O2 and 5% 
CO2.  EDL and SOL muscles were mounted vertically 
between two Radnoti (Monrovea, CA, USA) stimulat-
ing platinum electrodes and immersed in a 20 mL 
bathing chamber containing the incubation medium.  
The muscles were suspended from movable isometric 
force transducers above the chambers via the tendons, 
and secured to the base of the tissue support within the 
chambers. The analog output of the force transducer 
was digitized, stored and analyzed with PowerLab 
Software (Colorado Springs, CO, USA).  For each 
muscle, the resting tension and the stimulatory voltage 
were provided by a Grass S8800 digital stimulator 
(West Warwick, RI, USA) and both parameters were 
adjusted to produce a maximal isometric tetanic force 
(Tmax). 
 
Intact Muscle Protocol . After initial Tmax determination, 
the muscles were subjected to a protocol that mimics 
normal muscle activity (No fatigue, stimulation trains 
triggered at every minute, duty cycle of 2%). Muscles 
were placed in 2.5 mM Ca or zero Ca2+ and/or 5 mM 
NiCl2, 1 mm NiCl2, 10 μM nifedipine, or 25 μM 
bromoenol lactone (BEL). The intact muscles were 
allowed a 30-minute equilibration, during which time 
they were stimulated with pairs of alternating high (that 
produced Tmax) and low (that produced 1/2 Tmax) 
frequency pulse-trains administered with a periodicity 
of 1 minute, before any pharmacological intervention 
was attempted. The results indicate the relative 
contributions from the contractile proteins (Tmax) and 
from the SR (1/2 Tmax) to the stimulation [41].  
 
Intracellular Ca2+ Measurement and Mn2+ Quenching 










Ca2+], FDB muscle fibers were enzymatically isolated in 
a 0 Ca2+ Tyrode solution containing 2 mg/mL type I 
collagenase for 2 hours in a shaking bath at 37 °C, 
before being transferred to a 0 Ca2+ Tyrode solution 
without collagenase and gently triturated with a pipette.  
The fibers were then loaded with 5 µM Fura-2-AM for 
40 minutes, after which the Fura-2 AM was washed off. 
As fiber motion artifacts are associated with 
intracellular Ca release, 20 µM N-benzyl-p-toluene 
sulfonamide (Sigma, St. Louis, MO), a specific myosin 
II inhibitor, was then applied for 20 minutes.  A dual-
wavelength (excitation at 340 nm and 380 nm) PTI 
spectrofluorometer (Photon Technology International, 
Birmingham, NJ) was used to determine the kinetic 
changes of caffeine and ryanodine (C/R)-induced 
intracellular Ca2+ transients.   
 
Mn2+ quenching experiment were performed as 
previously described with minor modifications. Briefly, 
FDB fibers were loaded with Fura-2/AM fluorescent 
Ca2+ indicator [16].  SR Ca2+ depletion with C/R (with 
and without 25 µM BEL) was followed by the addition 
of 0.5 mM MnCl2 (with and without 25 µM BEL) to the 
extracellular solution. The Mn2+ quenching of Fura-2 
fluorescence was measured at the Ca2+-independent 
wavelength of Fura-2AM excitation (360 nm). The 
decay of Fura-2AM fluorescence upon Mn2+ addition 
was expressed as percent decrease in Fura-2 
fluorescence per unit time.  
 
Confocal Imaging of Store-operated calcium entry in 
mechanically-skinned muscle skinned muscle fiber. 
These studies followed our own protocols, which are 
based on our original and first ever methodology to 
directly monitor the spatial and temporal resolution of 
SOCE in mammalian skeletal muscle fibers [16,34]. 
Briefly, intact muscle fibers are carefully skinned in the 
present of 0.5mM CaCl2 and Rhod-5N, forcing the 
trapping of the dye and Ca+2 in the re-sealed T-tubules. 
Using IDL driven sub-routines, areas of interest 
comprising either the T-tubules or background areas can 
be drawn and the relative fluorescence upon activation of 
SOCE can be quantified. A minimum of 6 ROIs from 
each muscle fiber from 9 muscle fibers from 3 mice was 
employed to obtain the average SOCE activity in young 
and aged mice. 
 
 NaCl KCl CaCl2 NaH2PO4 MgCl2 Glucose EGTA 
Ca 135 5 2.5 0.4 0.5 10 --- 
0 Ca 135 5 --- 0.4 0.5 10 0.1 
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